Aclaris Therapeutics, Inc.

Current insiders at Aclaris Therapeutics, Inc.

• AKKARAJU SRINIVAS10% owner
• Ali-Jackson KamilChief Legal Officer
• Balthaser KevinChief Financial Officer
• Bierly RickDirector
• Biosion, Inc.10% owner
• Cawkwell GailChief Medical Officer
• CHA ALBERTDirector
• Davis Hugh M.Director
• Davis Hugh M.President and COO
• DEERFIELD CAPITAL LP10% owner
• DEERFIELD MANAGEMENT CO /NY10% owner
• DEERFIELD PARTNERS, LP10% owner
• Deerfield Special Situations Fund, L.P.Possible Member of a 10% Group
• Fair BrettChief Commercial Officer
• Flynn James E10% owner
• FMR LLCSee Remark 1
• Foresite Capital Fund III, L.P.10% owner
• Foresite Capital Fund IV, L.P.10% owner
• Foresite Capital Fund V, L.P.10% owner
• Foresite Capital Management III, LLC10% owner
• Foresite Capital Management IV, LLC10% owner
• Foresite Capital Management V, LLC10% owner
• Gordon David N.Chief Medical Officer
• GOWEN MAXINEDirector
• Hall Jesse WayneChief Medical Officer
• HEALY JAMES10% owner
• Humphries William D.Director
• Kolbeck Roland WilhelmChief Scientific Officer
• Kolchinsky Peter10% owner
• Leonard Braden Michael10% owner
• Loerop JamesChief Business Officer
• Manion Douglas J.Director
• Manion Douglas J.Pres and CEO
• Mehra AnandDirector
• Mehra Anand10% owner
• MILANO VINCENTDirector
• Molineaux Christopher P.Director
• Monahan JosephChief Scientific Officer
• Powala ChristopherChief Reg & Develop Officer
• Powell Andrew Kenneth WilliamDirector
• POWELL MICHAEL10% owner
• RA Capital Biotech Fund LP10% owner
• RA CAPITAL MANAGEMENT, LLC10% owner
• Reasons Bryan M.Director
• Ruffo FrankChief Financial Officer
• SCHIFF ANDREW NDirector
• Shanler StuartChief Scientific Officer
• Sofinnova Management VIII, L.L.C.10% owner
• Sofinnova Venture Partners VIII, L.P.10% owner
• Tananbaum James B.10% owner
• Tullman Stephen A.Director
• Vivo Ventures Fund VII, L.P.10% owner
• Vivo Ventures VII Affiliates Fund, L.P.10% owner
• VIVO VENTURES VII, LLC10% owner
• Walker NealDirector
• Walker NealCEO

Insider transaction history at Aclaris Therapeutics, Inc.